SGO Annual Meeting Abstracts Released
Effective March 28, 2020, the embargo on all abstracts accepted for the Society of Gynecologic Oncology (SGO) 2020 Annual Meeting on Women’s Cancer has been lifted.
SGO is also producing a webinar series covering the following topics:
- Surgical Innovations in Gynecologic Cancers
- Novel Discoveries in Endometrial Cancer: Are We Finally Making Progress?
- Paradigm Changes in Front Line Ovarian Cancer
- Molecular Testing and Patient Selection in Ovarian Cancer: How Do We Optimize PROs?
- Front Line Ovarian Cancer: Turning Up the Heat on Immunotherapy
- Rare Tumors
Given the rapidly evolving COVID-19 pandemic, these topics are subject to change based on presenter availability. More information to come.
In light of the global emergency of the new coronavirus, COVID-19, the Society of Gynecologic Oncology will not conduct its 2020 Annual Meeting on Women’s Cancer, March 28-31, in Toronto, Ontario, Canada. The health and safety of meeting attendees and the patients in their care is our utmost concern. In recent weeks, countries and institutions have imposed travel bans that prevent attendance by a significant number of attendees, including meeting faculty and SGO leadership, making it impossible to conduct the meeting at this time. SGO is exploring alternatives for delivering the science and education. Please watch for email notifications and updates on the sgoannualmeeting.org and sgo.org websites. We understand this decision raises several questions. We will be updating answers to your questions at MEETING UPDATE FAQS as information becomes available. Thank you for your understanding and support.
Access world-class education
Receive access to education on:
- The latest trends in global research, methods, and technology in treating gynecologic cancers
- Contemporary research findings on the prevention of and screening for gynecologic cancers
- Novel approaches to the medical and surgical management of gynecologic cancers within the context of the current standard of care
- Special interest topics for international attendees, residents, fellows, and candidates, cancer survivors, and allied health professionals